The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review
- 23 November 2012
- journal article
- review article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 30 (4) , 457-470
Abstract
Forty to fifty percent of colorectal cancer (CRC) patients develop colorectal liver metastases (CLM) that are either synchronous or metachronous in presentation. Clarifying whether there is a biological difference between the two groups of liver metastases or their primaries could have important clinical implications. A systematic review was performed using the following resources: MEDLINE from PubMed (1950 to present), Embase, Cochrane and the Web of Knowledge. Thirty-one articles met the inclusion criteria. The review demonstrated that the majority of studies found differences in molecular marker expression between colorectal liver metastases and their respective primaries in both the synchronous and metachronous groups. Studies investigating genetic aberrations demonstrated that the majority of changes in the primary tumour were ‘maintained’ in the colorectal liver metastases. A limited number of studies compared the primary tumours of the synchronous and metachronous groups and generally demonstrated no differences in marker expression. Although there were conflicting results, the colorectal liver metastases in the synchronous and metachronous groups demonstrated some differences in keeping with a more aggressive tumour subtype in the synchronous group. This review suggests that biological differences may exist between the liver metastases of the synchronous and metachronous groups. Whether there are biological differences between the primaries of the synchronous and metachronous groups remains undetermined due to the limited number of studies available. Future research is required to determine whether differences exist between the two groups and should include comparisons of the primary tumours.Keywords
This publication has 55 references indexed in Scilit:
- The Insulin Receptor Substrate 1 (Irs1) in Intestinal Epithelial Differentiation and in Colorectal CancerPLOS ONE, 2012
- Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastasesBMC Cancer, 2012
- DNA Methylation Profiles of Primary Colorectal Carcinoma and Matched Liver MetastasisPLOS ONE, 2011
- Molecular alterations associated with liver metastases development in colorectal cancer patientsBritish Journal of Cancer, 2011
- Colorectal Liver MetastasesInternational Journal of Surgical Oncology, 2011
- Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastasesBritish Journal of Cancer, 2010
- Clinicopathologic Significance of HIF‐1α, CXCR4, and VEGF Expression in Colon CancerJournal of Immunology Research, 2010
- IRS1 Regulation by Wnt/β-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic PhenotypeJournal of Biological Chemistry, 2010
- Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choiceBritish Journal of Cancer, 2008
- A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancersNature Genetics, 2006